摘要 |
FIELD: medicine.SUBSTANCE: group of inventions relates to medicine, namely to cardiology, and can be used for creation of agent for reducing risk of increased QT dispersion in patient. For this L-carnitine solution is introduced intravenous.EFFECT: group of inventions allows to reduce risk of fatal arrhythmia progression by reducing oxidative stress in MX cells (mitochondria) in patients, suffering of acute coronary syndrome, particularly unstable angina or myocardial infarction.10 cl, 2 dwg, 7 tbl |